Corbus Pharmaceuticals Holdings (CRBP) Total Current Liabilities (2013 - 2025)

Corbus Pharmaceuticals Holdings' Total Current Liabilities history runs 13 years deep, the most recent figure standing at $20.7 million for Q4 2025.

• In Q4 2025, Total Current Liabilities rose 75.09% year-over-year to $20.7 million; the TTM figure through Dec 2025 stood at $20.7 million (up 75.09% YoY), while the FY2025 annual figure was $20.7 million, up 75.09% from the prior year.
• Total Current Liabilities was $20.7 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $17.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $31.9 million in Q4 2023 to a low of $11.6 million in Q1 2025.
• Historically, Total Current Liabilities has averaged $18.4 million across 5 years, with a median of $17.0 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities soared 152.33% in 2023, then sank 63.14% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $17.0 million in 2021, then decreased by 25.68% to $12.6 million in 2022, then surged by 152.33% to $31.9 million in 2023, then tumbled by 62.95% to $11.8 million in 2024, then jumped by 75.09% to $20.7 million in 2025.
• The last three Total Current Liabilities figures came in at $20.7 million (Q4 2025), $17.1 million (Q3 2025), and $13.3 million (Q2 2025), per Business Quant data.